Perfil
Matthew B. Frankel formerly worked at Reata Pharmaceuticals, Inc., as Global Medical Director from 2010 to 2012, Boehringer Ingelheim Pharmaceuticals, Inc., as VP-Clinical Development & Medical Affairs from 2018 to 2022, Novartis Pharmaceuticals Corp., as VP, Head-Immunology & Dermatology from 2016 to 2018, and Chemomab Therapeutics Ltd., as Chief Medical Officer & VP-Drug Development from 2022 to 2025.
Dr. Frankel received his undergraduate degree from Vassar College, doctorate degree from David Geffen School of Medicine, and Masters Business Admin degree from Kellogg School of Management.
Antiguos cargos conocidos de Matthew Frankel.
| Empresas | Cargo | Fin |
|---|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Director Técnico/Científico/I+D | 15/04/2025 |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Director Técnico/Científico/I+D | 01/11/2022 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01/01/2018 |
| REATA PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/01/2012 |
Formación de Matthew Frankel.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics which regulates cellular metabolism and inflammation in serious neurologic diseases | Health Technology |
Vassar College
Vassar College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
David Geffen School of Medicine
David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotech company | Health Technology |
- Bolsa de valores
- Insiders
- Matthew Frankel
















